Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
CDK4/6–BET Synergy in Pancreatic Cancer
2026-08-13
Gu et al. show that palbociclib can inhibit pancreatic tumor cell growth while paradoxically intensifying migration, invasion, and epithelial-to-mesenchymal transition through GSK3β-mediated Wnt/β-catenin activation. BET inhibition with JQ1 counteracted these effects and produced synergistic antitumor activity in cell models and an orthotopic pancreatic cancer model, providing a mechanistic rationale for combination treatment.
-
BMP4-GPX4 Protects RGCs in Glaucoma Models
2026-08-12
The reference study identifies the BMP4-GPX4 axis as a regulator of ferroptosis-associated retinal ganglion cell injury and as a potential enhancer of retinal stem cell differentiation after transplantation. Its integrated use of a mouse retinal injury model, transcriptomic analysis, redox measurements, and protein-level validation links oxidative stress and iron accumulation with a regenerative cell-therapy strategy.
-
Tetracycline Hydrochloride: From Mechanism to Translation
2026-08-12
A translational strategy for using Tetracycline Hydrochloride in antimicrobial and skin microbiome research, while distinguishing its ribosomal mechanism from emerging ROS-driven cancer therapeutics.
-
EdU Imaging Kits (HF594): Practical Workflow
2026-08-11
EdU Imaging Kits (HF594), SKU K2243, provide an endpoint method for measuring S-phase DNA synthesis through EdU incorporation and HyperFluor™ 594 click-chemistry detection. They are suitable for fluorescence microscopy and flow cytometry proliferation assays, but signal should not be interpreted as a direct measure of completed cell division, viability, or long-term growth without supporting controls.
-
N1-Methylpseudo-UTP: A Translational Design Lever
2026-08-11
N1-Methyl-Pseudouridine-5'-Triphosphate can be more than an RNA synthesis reagent: it is a controllable variable in the design of stable, efficiently translated mRNA payloads. This thought-leadership analysis connects nucleotide chemistry with the antigen–adjuvant and delivery strategy demonstrated in a recent influenza mRNA lipid nanoparticle study.
-
740 Y-P: PI3K Activation Protocol and QC
2026-08-10
740 Y-P is a cell-permeable PI 3-kinase activator for controlled modulation of PI3K/AKT signaling in vesicular trafficking, survival, and cancer research workflows. It is suitable for exploratory cellular assays, but it should not be treated as a universal dose standard or used when ethanol-based formulation or long-term solution storage is required.
-
CH 223191: Mapping AhR-Driven Ovarian Toxicity
2026-08-09
CH 223191 is a potent aryl hydrocarbon receptor antagonist for resolving how environmental ligands alter endocrine tissues. This guide translates ovarian follicle evidence into a pathway-centered assay strategy that distinguishes AhR engagement from nonspecific toxicity.
-
Self-Amplifying RNA Vaccines for Seasonal Influenza
2026-08-08
This 2026 study shows that self-amplifying RNA can overcome the weak influenza B immunogenicity observed with conventional nucleoside-modified mRNA in mice. At a low dose, trivalent saRNA generated durable antibody responses and complete protection against influenza B challenge, highlighting platform- and subtype-specific determinants of RNA vaccine performance.
-
Tivozanib (AV-951): Measure More Than Viability
2026-08-07
Tivozanib (AV-951) is a selective VEGFR inhibitor whose biology can be obscured by conventional viability assays. This guide connects VEGFR pathway pharmacology with a more rigorous framework for separating growth inhibition from true cell killing in oncology research.
-
Radioiodinated Balsalazide: Advancing UC Imaging in Mice
2026-08-07
Sanad et al. present a robust protocol for radioiodinating balsalazide, yielding a highly selective, stable radiotracer for imaging ulcerative colitis (UC) in mice. Their work enables precise, extended biodistribution studies in preclinical UC models, addressing key shortcomings of prior radiotracers.
-
H 89 2HCl: Precision PKA Inhibition in cAMP Signaling Assays
2026-08-06
H 89 2HCl empowers researchers to dissect cAMP/PKA signaling with high selectivity and reproducibility, as evidenced in studies on neuronal calcium modulation and protein phosphorylation. This article demystifies experimental workflows, protocol tuning, and troubleshooting strategies for leveraging H 89 2HCl in advanced cellular models.
-
NMDA (N-Methyl-D-aspartic acid) in Advanced Excitotoxicity M
2026-08-06
Leverage NMDA (N-Methyl-D-aspartic acid) for highly reproducible modeling of excitotoxicity, ferroptosis, and neurodegeneration. This article delivers optimized protocols, troubleshooting essentials, and practical insights from cutting-edge glaucoma research to power your next neuroscience experiment.
-
Pregnenolone Carbonitrile: Advanced Workflows in Hepatic and
2026-08-05
Pregnenolone Carbonitrile stands out as a versatile tool for dissecting PXR-mediated hepatic detoxification and unraveling glucocorticoid receptor-dependent neuroprotection. This article translates cutting-edge reference findings and best practices into actionable protocols, troubleshooting tips, and workflow innovations for biomedicine.
-
GSK621: Advanced AMPK Agonist for AML and Metabolic Research
2026-08-05
GSK621, a potent AMPK agonist from APExBIO, delivers unmatched control over metabolic and immunometabolic pathways, setting a benchmark in apoptosis and autophagy studies—especially in acute myeloid leukemia research. Explore optimized protocols, troubleshooting strategies, and insights from the latest immunometabolic reference study to accelerate your research outcomes.
-
Reactive Oxygen Species Assay Kit (DHE): Mechanism & Benchma
2026-08-04
The Reactive Oxygen Species Assay Kit (DHE) enables precise detection of intracellular superoxide in living cells using a dihydroethidium (DHE) probe. This kit supports robust oxidative stress assays and advanced apoptosis research workflows by providing quantitative, reproducible results. APExBIO’s K2066 kit is benchmarked by peer-reviewed evidence and optimally designed for redox biology applications.